BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Sonida Senior Living
SNDA
$1.91B
| $1.8M | ﹤0.01% |
36,332
-2,790
| -7% | -$124K |
|
4152
Mannatech
MTEX
$9.24M
| $1.78M | ﹤0.01% |
64,355
-8,241
| -11% | -$183K |
|
4153
Savara
SVRA
$1.12B
| $1.78M | ﹤0.01% |
1,048,635
-2,080,345
| -66% | -$3.74M |
|
4154
US Global Investors
GROW
$35.5M
| $1.78M | ﹤0.01% |
287,604
-58,177
| -17% | -$414K |
|
4155
B2Gold
BTG
$5B
| $1.77M | ﹤0.01% |
420,932
+20,356
| +5% | +$99.4K |
|
4156
Ocean Power Technologies
OPTT
$48.9M
| $1.77M | ﹤0.01% |
708,420
-3,627
| -0.5% | -$8.98K |
|
|
HIMX
4157
Himax Technologies
HIMX
$2.19B
| $1.77M | ﹤0.01% |
106,188
-396
| -0.4% | -$5.23K |
|
|
AIM
4158
AIM ImmunoTech
AIM
$7.03M
| $1.77M | ﹤0.01% |
8,235
-1,565
| -16% | -$335K |
|
4159
Actinium Pharmaceuticals
ATNM
$26.3M
| $1.76M | ﹤0.01% |
222,532
+22,699
| +11% | +$178K |
|
|
ALR
4160
DELISTED
AlerisLife Inc
ALR
| $1.75M | ﹤0.01% |
304,586
-1,042,593
| -77% | -$5.94M |
|
|
STEX
4161
Streamex Corp
STEX
$74M
| $1.75M | ﹤0.01% |
45,414
-130,390
| -74% | -$4.87M |
|
4162
Aprea Therapeutics
APRE
$7.68M
| $1.74M | ﹤0.01% |
17,881
-22,662
| -56% | -$2.09M |
|
4163
Traws Pharma
TRAW
$6.85M
| $1.74M | ﹤0.01% |
10,056
-1,872
| -16% | -$424K |
|
|
AGRX
4164
DELISTED
Agile Therapeutics
AGRX
| $1.74M | ﹤0.01% |
654
-1,895
| -74% | -$6.25M |
|
4165
West Fraser Timber
WFG
$5.08B
| $1.72M | ﹤0.01% |
23,982
+20,011
| +504% | +$1.54M |
|
|
AIU
4166
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
| $1.72M | ﹤0.01% |
11,170
-174
| -2% | -$43.6K |
|
4167
X4 Pharmaceuticals
XFOR
$375M
| $1.71M | ﹤0.01% |
8,776
-27,616
| -76% | -$6.94M |
|
4168
MINISO
MNSO
$3.88B
| $1.71M | ﹤0.01% |
82,217
+12,314
| +18% | +$295K |
|
4169
Cyclerion Therapeutics
CYCN
$14.9M
| $1.7M | ﹤0.01% |
21,807
-62,467
| -74% | -$3.91M |
|
|
RNWK
4170
DELISTED
RealNetworks Inc
RNWK
| $1.69M | ﹤0.01% |
726,426
+26,957
| +4% | +$78.6K |
|
4171
KORU Medical Systems
KRMD
$189M
| $1.69M | ﹤0.01% |
363,889
-1,309,423
| -78% | -$5.14M |
|
4172
iShares MSCI Kuwait ETF
KWT
$71.6M
| $1.68M | ﹤0.01% |
53,000
| – | – |
|
|
RTP.WS
4173
DELISTED
Reinvent Technology Partners Redeemable Warrants, each whole warrant exercisable for one Class A ord
RTP.WS
| $1.68M | ﹤0.01% |
861,457
| – | – |
|
|
BKCC
4174
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.67M | ﹤0.01% |
425,709
+36,193
| +9% | +$143K |
|
4175
Stantec
STN
$8.04B
| $1.67M | ﹤0.01% |
37,423
+6,077
| +19% | +$274K |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.